BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 14978695)

  • 1. Acquired amegakaryocytic thrombocytopenia purpura and eosinophilic fasciitis: a long relapsing and remitting course.
    Chaudhary UB; Eberwine SF; Hege KM
    Am J Hematol; 2004 Mar; 75(3):146-50. PubMed ID: 14978695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired amegakaryocytic thrombocytopenic purpura.
    Agarwal N; Spahr JE; Werner TL; Newton DL; Rodgers GM
    Am J Hematol; 2006 Feb; 81(2):132-5. PubMed ID: 16432869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired amegakaryocytic thrombocytopenic purpura (AATP): a study of autologous megakaryocyte progenitors and the effect of patients plasma on normal marrow megakaryocyte colony formation.
    Podolak-Dawidziak M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):347-51. PubMed ID: 1697840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired amegakaryocytic thrombocytopenic purpura: review of a not very well-defined disorder.
    Tristano AG
    Eur J Intern Med; 2005 Nov; 16(7):477-81. PubMed ID: 16275539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amegakaryocytic thrombocytopenia of 4 years duration: successful treatment with antithymocyte globulin.
    Trimble MS; Glynn MF; Brain MC
    Am J Hematol; 1991 Jun; 37(2):126-7. PubMed ID: 2069157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful cyclosporin A therapy for acquired amegakaryocytic thrombocytopenic purpura.
    Azuno Y; Yaga K
    Am J Hematol; 2002 Apr; 69(4):298-9. PubMed ID: 11921030
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acquired amegakaryocytic thrombocytopenic purpura treated with intravenous immunoglobulins].
    El Omri H; Skouri H; Kraiem I; Latiri A; Khelif A; Korbi S; Ennabli S
    Ann Med Interne (Paris); 2000 May; 151(3):223-6. PubMed ID: 10896976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful rituximab treatment for acquired amegakaryocytic thrombocytopenic purpura complicated with Coombs-negative autoimmune hemolytic anemia].
    Hashimoto A; Fujimi A; Kanisawa Y; Matsuno T; Okuda T; Minami S; Doi T; Ishikawa K; Uemura N; Tomaru U
    Rinsho Ketsueki; 2013 Jun; 54(6):568-73. PubMed ID: 23823096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between megakaryocyte mass and serum thrombopoietin levels as revealed by a case of cyclic amegakaryocytic thrombocytopenic purpura.
    Zent CS; Ratajczak J; Ratajczak MZ; Anastasi J; Hoffman PC; Gewirtz AM
    Br J Haematol; 1999 May; 105(2):452-8. PubMed ID: 10233421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T suppressor activated lymphocytes (CD8+/DR+) inhibit megakaryocyte progenitor cell differentiation in a case of acquired amegakaryocytic thrombocytopenic purpura.
    Benedetti F; de Sabata D; Perona G
    Stem Cells; 1994 Mar; 12(2):205-13. PubMed ID: 8199563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine abnormalities in a patient with eosinophilic fasciitis.
    Dziadzio L; Kelly EA; Panzer SE; Jarjour N; Huttenlocher A
    Ann Allergy Asthma Immunol; 2003 Apr; 90(4):452-5. PubMed ID: 12722970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired amegakaryocytic thrombocytopenia after durvalumab administration.
    Suyama T; Hagihara M; Kubota N; Osamura Y; Shinka Y; Miyao N
    J Clin Exp Hematop; 2021 Mar; 61(1):53-57. PubMed ID: 33431742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid progression of acquired amegakaryocytic thrombocytopenia to aplastic anemia.
    King JA; Elkhalifa MY; Latour LF
    South Med J; 1997 Jan; 90(1):91-4. PubMed ID: 9003837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired amegakaryocytic thrombocytopenic purpura with humoral inhibitory factor for megakaryocyte colony formation.
    Katai M; Aizawa T; Ohara N; Hiramatsu K; Hashizume K; Yamada T; Kitano K; Saito H; Shinoda T; Wakata S
    Intern Med; 1994 Mar; 33(3):147-9. PubMed ID: 8061390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of successfully treated cyclic amegakaryocytic thrombocytopenic purpura].
    Telek B; Kiss A; Pecze K; Ujhelyi P; Rák K
    Orv Hetil; 1990 May; 131(20):1085-7. PubMed ID: 2345648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature.
    Bischoff L; Derk CT
    Int J Dermatol; 2008 Jan; 47(1):29-35. PubMed ID: 18173597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired amegakaryocytic thrombocytopenic purpura associated with immunoglobulin deficiency.
    Rovira M; Feliu E; Florensa L; Woessner S; Tassies D; Montserrat E; Vives-Corrons JL; Rozman C
    Acta Haematol; 1991; 85(1):34-6. PubMed ID: 2011928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of acquired amegakaryocytic thrombocytopenic purpura refractory to corticosteroids and intravenous immunoglobulin with antithymocyte globulin and cyclosporin.
    Niparuck P; Atichartakarn V; Chuncharunee S
    Int J Hematol; 2008 Sep; 88(2):223-226. PubMed ID: 18626728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired amegakaryocytic thrombocytopenic purpura successfully treated with limited cyclosporin A therapy.
    Quintás-Cardama A
    Eur J Haematol; 2002 Sep; 69(3):185-6. PubMed ID: 12406014
    [No Abstract]   [Full Text] [Related]  

  • 20. Eosinophilic fasciitis in a female child.
    Ortega-Loayza AG; Merritt BG; Groben PA; Morrell DS
    J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S72-4. PubMed ID: 18489052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.